Teresa Cejalvo

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Toll Like Receptor

Cerebrospinal Fluid

Top Venues

Cancer research communications

Cancer immunology, immunotherapy : CII

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Álvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Stefano Gambera, Teresa Cejalvo, Belén de Andrés, María-Luisa Gaspar, Javier García-Castro
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing. Cancer research communications 3 (3) (2023)
Álvaro Morales-Molina, Miguel Ángel Rodríguez-Milla, Stefano Gambera, Teresa Cejalvo, Belén de Andrés, María-Luisa Gaspar, Javier García-Castro
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing. Cancer research communications 3 (3) (2023)
Berta Segura-Collar, María Garranzo-Asensio, Beatriz Herránz, Esther Hernandez-SanMiguel, Teresa Cejalvo, Bárbara S Casas, Ander Matheu, Ángel Pérez-Núñez, Juan Manuel Sepúlveda Sánchez, Aurelio Hernández-Laín, Verónica Palma, Ricardo Gargini, Vicente A Torres
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas. Cancer research 81 (8) (2021)
Teresa Cejalvo, Ricardo Gargini, Berta Segura-Collar, Pablo Mata-Martínez, Beatriz Herranz, Diana Cantero, Yolanda Ruano, Daniel García-Pérez, Ángel Pérez-Núñez, Ana Ramos, Aurelio Hernández-Laín, María Cruz Martín-Soberón, Vicente A Torres, Juan Manuel Sepúlveda Sánchez
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype. Cancers 12 (11) (2020)
Álvaro Morales-Molina, Stefano Gambera, Teresa Cejalvo, Rafael Moreno, Miguel Ángel Rodríguez-Milla, Ana Judith Perisé-Barrios, Javier García-Castro
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice. Cancer immunology, immunotherapy : CII 67 (10) (2018)